Cleveland Clinic-Led Trial Finds High Doses of a Prescription Fish Oil Do Not Reduce Major Cardiac Events in High-Risk Patients

CLEVELAND, Nov. 15, 2020 /PRNewswire/ -- Findings from a new Cleveland Clinic study do not support the use of a high dose omega-3 fatty acid formulation to reduce major adverse cardiovascular events in patients with high cardiovascular risk. Findings from the STRENGTH Trial:...

from PR Newswire: https://ift.tt/2H9bvF6